Diabetes (DM) is associated with micro- and macrovascular complications and impaired wound healing which leads to the formation of chronic lesions. Mesenchymal stem cells exert anti-inflammatory and secretory actions and their use in chronic lesions has obtained a high success rate, improving the healing process. In the present study, we have evaluated the effects of the use of a lineage of human mesenchymal cells obtained from bone marrow cells and immortalized by the enzyme telomerase (hBMSC-TERT), in wound healing in diabetics and their possible mechanism as regulators of MMPs. Male Wistar rats were divided into 6 groups (n = 8): Control without injury, Control with injury, Control with injury + hBMSC-TERT, Diabetics without injury, Diabetics with injury, Diabetics with injury + hBMSC-TERT. DM was induced by intraperitoneal injection of streptozotocin (60 mg/kg) and cutaneous lesions were performed in the dorsal region with the use of a punch (6 mm). Three weekly subcutaneous injections of hBMSC-TERT (1x106) into the lesion were performed. Thirteen days after the last injection, euthanasia and the collection of cutaneous tissue were performed for histological analysis (hematoxylin-eosin) and MMP-2 activity determination by gelatin zymography. The presence of fibroblasts and inflammatory infiltrate was significantly lower (p <0.05) in infused diabetic animals when compared to those non-infused, indicating an improvement of the healing process in the diabetic group treated with hBMSC-TERT. The diabetic animals infused with hBMSC-TERT showed improvement in the healing process with respect to the amount and organization of collagen when compared to diabetic animals that did not receive an infusion of hBMSC-TERT. The levels of pro MMP-2 were significantly higher in Control with injury group than in Control group treated with hBMSC-TERT and in diabetic animals.

In conclusion, the data indicate that hBMSC-TERT may become an important therapeutic tool.


Â.M. Leal: None.

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.